Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - desogestrel, quantity: 150 microgram; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: povidone; titanium dioxide; magnesium stearate; maize starch; hypromellose; polysorbate 80; triacetin; indigo carmine aluminium lake; colloidal anhydrous silica; iron oxide yellow; lactose monohydrate - oral contraception

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - desogestrel, quantity: 150 microgram; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: magnesium stearate; lactose monohydrate; potato starch - oral contraception.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cyproterone acetate 2mg;  ; ethinylestradiol 0.035mg;   - film coated tablet - active: cyproterone acetate 2mg   ethinylestradiol 0.035mg   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry buff oy-3690 opadry white y-1r-7000b opaglos white 6000 povidone purified water quinoline yellow sucrose lactose monohydrate magnesium stearate microcrystalline cellulose - estelle-35 and estelle-35 ed are indicated for the treatment of androgen dependent diseases in women, such as acne (where oral antibiotics or local treatment alone has not been successful), especially pronounced forms and those which are accompanied by seborrhoea or by inflammation or formation of nodes (acne papulopustulosa, acne nodulocystica), androgenic alopecia, mild forms of hirsutism. estelle-35 and estelle-35 ed are also indicated for oral contraception in women requiring treatment for these androgen-dependent diseases; it is not recommended in women solely for contraception. estelle-35 and estelle-35 ed are also indicated for treating the symptoms of polycystic ovary syndrome.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - ethinylestradiol, quantity: 0.03 mg; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: titanium dioxide; purified talc; lactose monohydrate; magnesium stearate; hypromellose; microcrystalline cellulose - indications: petibelle is indicated for use as an oral contraceptive.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - ethinylestradiol, quantity: 0.03 mg; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: lactose monohydrate; purified talc; titanium dioxide; magnesium stearate; hypromellose; microcrystalline cellulose - indications: yasmin is indicated for use as an oral contraceptive.

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - levonorgestrel micronized; levonorgestrel micronized; levonorgestrel micronized; ethinylestradiol micronized; ethinylestradiol micronized - coated tablet - percent volume/volume - progestogens and estrogens, sequential preparations; levonorgestrel and ethinylestradiol

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - ethinylestradiol 0.05mg; levonorgestrel 0.125mg - tablet - active: ethinylestradiol 0.05mg levonorgestrel 0.125mg excipient: calcium carbonate glycerol wax e iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone as polyvidone 25,000   purified talc   sucrose titanium dioxide calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose - oral contraception

Malta - English - Medicines Authority

bayer plc - dienogest; estradiol valerate - film-coated tablet - dienogest 4.41 mg; estradiol valerate - sex hormones and modulators of the genital system

Malta - English - Medicines Authority

bayer public limited company 400 south oak way, reading berkshire rg2 6ad, united kingdom - drospirenone, ethinylestradiol - film-coated tablet - drospirenone 3 mg ethinylestradiol 0.02 mg - sex hormones and modulators of the genital system

United Kingdom - English - myHealthbox

morningside healthcare limited - ethinylestradiol, drospirenone - tablets - 0.03mg/3mg - progestogens and estrogens, fixed combinations - oral contraception.